MCM
CNMD icon

Moore Capital Management’s CONMED CNMD Stock Holding History

Moore Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$826K Buy
25,230
+651
+3% +$23.4K 0.01% 504
2026
Q1 		$869K Hold
24,579
– – 0.02% 383
2025
Q4 		$998K Buy
24,579
+4,945
+25% +$215K 0.01% 459
2025
Q3 		$923K Buy
19,634
+6,630
+51% +$344K 0.01% 438
2025
Q2 		$677K Buy
+13,004
New +$714K 0.01% 409

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Moore Capital Management's CNMD Position: Q2 2026 in Review

Moore Capital Management increased its CONMED (CNMD) stake by 2.6% in Q2 2026, buying an estimated $23.4K and bringing the position to 25,230 shares worth $826K. The position accounts for 0.01% of the portfolio, ranked #504.

Moore Capital Management first reported a position in CNMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $998K in Q4 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Moore Capital Management held 25,230 shares of CONMED worth $826K as of Q2 2026.
  • Moore Capital Management bought 651 CONMED shares in Q2 2026, an estimated $23.4K.
  • CONMED made up 0.01% of Moore Capital Management's portfolio in Q2 2026, its #504 holding.
  • Moore Capital Management first reported a position in CONMED in Q2 2025 and has held it in 5 quarters since.
  • Moore Capital Management's CONMED position peaked at $998K in Q4 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.